Startup lab Theranos isn't utilizing its 'finger prick' blood checks a lot
Theranos, the $9 billion Silicon Valley startup that guarantees blood check outcomes with only a finger prick, is underneath critical scrutiny. In line with The Wall Road Journal, FDA investigators lately confirmed up unannounced to examine its laboratory, as a consequence of considerations concerning the
